发明名称 Pharmaceutical composition
摘要 <p>It is described a solid, sustained-release, oral dosage form pharmaceutical compositions which contain therapeutic amounts of a pharmaceutically active agent, hydroxypropyl methyl cellulose and a non-ionic hydrophilic polymer selected from the group consisting of hydroxyethyl cellulose having a number average molecular weight ranging from 90000 to 1300000, hydroxypropyl cellulose having a number average molecular weight of 370000 to 1500000 and poly(ethylene oxide) having a number average molecular weight ranging from 100000 to 500000.</p>
申请公布号 SK286595(B6) 申请公布日期 2009.01.07
申请号 SK20010000509 申请日期 1999.10.12
申请人 NOVARTIS AG 发明人 SHAH RAJEN;PATEL ARUN P.;SANDRY ROY T.
分类号 A61K47/34;A61K9/20;A61K9/22;A61K31/22;A61K31/351;A61K31/40;A61K31/404;A61K31/4045;A61K31/4418;A61K47/38;A61P3/06;A61P3/12;A61P7/02;A61P9/00;A61P9/06;A61P9/10;A61P9/12;A61P11/06;A61P13/02;A61P19/02;A61P25/08;A61P25/20;A61P25/22;A61P25/24;A61P29/00;A61P43/00 主分类号 A61K47/34
代理机构 代理人
主权项
地址